1
|
Yekeler HB, Guler E, Beato PS, Priya S, Abobakr FKM, Dogan M, Uner B, Kalaskar DM, Cam ME. Design and in vitro evaluation of curcumin-loaded PLGA nanoparticle-embedded sodium alginate/gelatin 3D printed scaffolds for Alzheimer's disease. Int J Biol Macromol 2024; 268:131841. [PMID: 38679260 DOI: 10.1016/j.ijbiomac.2024.131841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 04/18/2024] [Accepted: 04/23/2024] [Indexed: 05/01/2024]
Abstract
BACKGROUND Targeted nanoparticles (NPs) are aimed at improving clinical outcomes by enhancing the diagnostic and therapeutic efficacy of drugs in the treatment of Alzheimer's disease (AD). METHODS Curcumin (CUR)-loaded poly-lactic-co-glycolic acid (PLGA) NPs (CNPs) were produced to demonstrate a prolonged release and successfully embedded into 3D printed sodium alginate (SA)/gelatin (GEL) scaffolds that can dissolve rapidly sublingually. Characterization and in vitro activity of the NPs and scaffolds were evaluated. RESULTS Based on the in vitro drug release studies, 99.6 % of the encapsulated CUR was released in a controlled manner within 18 days for the CNPs. In vitro cell culture studies showed that all samples exhibited cell viability above 84.2 % and no significant cytotoxic effect on SH-SY5Y cells. The samples were analyzed through 2 different pathways by PCR analysis. Real-time PCR results indicated that CNP and CNP-embedded SA/GEL scaffolds (CNPSGS) may show neuroprotective effects by modulating the Wnt/β-catenin pathway. The gene expression level of β-catenin slightly increased compared to the gene expression levels of other proteins and enzymes with these treatments. However, the PI3K/Akt/GSK-3β signaling pathway was regulated at the same time because of the crosstalk between these 2 pathways. CONCLUSION CNPSGS might be an effective therapeutic alternative for AD treatment.
Collapse
Affiliation(s)
- Humeyra Betul Yekeler
- Department of Pharmacology, Faculty of Pharmacy, Marmara University, Istanbul 34854, Türkiye; Center for Nanotechnology and Biomaterials Application and Research, Marmara University, Istanbul 34722, Türkiye; UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK; MecNano Technologies, Cube Incibation, Teknopark Istanbul, Istanbul 34906, Türkiye
| | - Ece Guler
- Center for Nanotechnology and Biomaterials Application and Research, Marmara University, Istanbul 34722, Türkiye; UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK; MecNano Technologies, Cube Incibation, Teknopark Istanbul, Istanbul 34906, Türkiye; Department of Pharmacology, Faculty of Pharmacy, Istanbul Kent University, Kagithane 34406, Istanbul, Türkiye
| | - Patricia Santos Beato
- UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK
| | - Sushma Priya
- UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK
| | | | - Murat Dogan
- Department of Pharmaceutical Biotechnology, Cumhuriyet University, Sivas 58140, Türkiye; Cancer Survivorship Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 625 N. Michigan Ave., Suite 2100, Chicago, IL, 60611, USA
| | - Burcu Uner
- Department of Pharmaceutical and Administrative Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, MO, USA; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul Kent University, Kagithane 34406, Istanbul, Türkiye
| | - Deepak M Kalaskar
- UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK
| | - Muhammet Emin Cam
- Center for Nanotechnology and Biomaterials Application and Research, Marmara University, Istanbul 34722, Türkiye; UCL Division of Surgery and Interventional Science, Royal Free Hospital Campus, University College London, Rowland Hill Street, NW3 2PF, UK; MecNano Technologies, Cube Incibation, Teknopark Istanbul, Istanbul 34906, Türkiye; Department of Pharmacology, Faculty of Pharmacy, Istanbul Kent University, Kagithane 34406, Istanbul, Türkiye; Biomedical Engineering Department, University of Aveiro, Aveiro 3810-193, Portugal; Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, Istanbul 34854, Türkiye.
| |
Collapse
|
2
|
Guler E, Yekeler HB, Parviz G, Aydin S, Asghar A, Dogan M, Ikram F, Kalaskar DM, Cam ME. Vitamin B 12-loaded chitosan-based nanoparticle-embedded polymeric nanofibers for sublingual and transdermal applications: Two alternative application routes for vitamin B 12. Int J Biol Macromol 2024; 258:128635. [PMID: 38065445 DOI: 10.1016/j.ijbiomac.2023.128635] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Revised: 11/19/2023] [Accepted: 12/03/2023] [Indexed: 01/06/2024]
Abstract
Alzheimer's disease (AD) is a neurodegeneration type that is biologically recognizable via β-amyloid plaques and tau neurofibril tangles. Global estimation for the total count of individuals enduring AD will rise up to 131 million by 2050. Investigations suggested the existence of a direct proportion between the likelihood of AD occurrence and vitamin B12 (VB12) hypovitaminosis. Approved VB12 administrations, intramuscular and oral, each has serious defects broaching the demand for alternative routes. This work developed VB12-loaded chitosan/tripolyphosphate/polyvinyl alcohol (CS/TPP/PVA) nanoparticles (NPs) embedded in polyvinylpyrrolidone (PVP) and polyvinylpyrrolidone/polycaprolactone (PVP/PCL) nanofibrous (NFs) produced by pressurized gyration (PG) for sublingual and transdermal routes, respectively. Biomaterials were investigated morphologically, chemically, and thermally. Moreover, degradation, disintegration, release behavior, and release kinetics were analyzed. The effectiveness and safety of nanomaterials were assessed and proven with the alamarBlue test on the Aβ1-42-induced SH-SY5Y model. The final evaluation suggested the feasibility, safety, and effectiveness of produced systems. Consequently, two alternative VB12 application routes were developed with high effectivity and low toxicity with the power of nanotechnology.
Collapse
Affiliation(s)
- Ece Guler
- Department of Pharmacology, Faculty of Pharmacy, İstanbul Kent University, İstanbul 34406, Türkiye; Department of Pharmacology, Faculty of Pharmacy, Marmara University, İstanbul 34854, Türkiye; Center for Nanotechnology and Biomaterials Application and Research, Marmara University, İstanbul 34722, Türkiye; UCL Division of Surgery and Interventional Sciences, Rowland Hill Street, NW3 2PF London, UK; MecNano Technologies, Cube Incibation, Teknopark İstanbul, İstanbul 34906, Türkiye
| | - Humeyra Betul Yekeler
- Department of Pharmacology, Faculty of Pharmacy, Marmara University, İstanbul 34854, Türkiye; Center for Nanotechnology and Biomaterials Application and Research, Marmara University, İstanbul 34722, Türkiye; UCL Division of Surgery and Interventional Sciences, Rowland Hill Street, NW3 2PF London, UK; MecNano Technologies, Cube Incibation, Teknopark İstanbul, İstanbul 34906, Türkiye
| | - Gita Parviz
- Department of Pharmacology, Faculty of Pharmacy, Marmara University, İstanbul 34854, Türkiye; Center for Nanotechnology and Biomaterials Application and Research, Marmara University, İstanbul 34722, Türkiye; MecNano Technologies, Cube Incibation, Teknopark İstanbul, İstanbul 34906, Türkiye
| | - Saliha Aydin
- Department of Pharmacology, Faculty of Pharmacy, Marmara University, İstanbul 34854, Türkiye
| | - Asima Asghar
- Interdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus, Pakistan
| | - Murat Dogan
- Sivas Cumhuriyet University, Pharmacy Faculty, Pharmaceutical Biotechnology Department, Sivas, Türkiye
| | - Fakhera Ikram
- Interdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus, Pakistan.
| | - Deepak M Kalaskar
- UCL Division of Surgery and Interventional Sciences, Rowland Hill Street, NW3 2PF London, UK
| | - Muhammet Emin Cam
- Department of Pharmacology, Faculty of Pharmacy, İstanbul Kent University, İstanbul 34406, Türkiye; Department of Pharmacology, Faculty of Pharmacy, Marmara University, İstanbul 34854, Türkiye; Center for Nanotechnology and Biomaterials Application and Research, Marmara University, İstanbul 34722, Türkiye; UCL Division of Surgery and Interventional Sciences, Rowland Hill Street, NW3 2PF London, UK; MecNano Technologies, Cube Incibation, Teknopark İstanbul, İstanbul 34906, Türkiye; Biomedical Engineering Department, University of Aveiro, 3810-193 Aveiro, Portugal; Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, İstanbul 34854, Türkiye; SFA R&D Laboratories, Teknopark İstanbul, İstanbul 34906, Türkiye; ATA BIO Technology, Teknopol İstanbul, İstanbul 34930, Türkiye.
| |
Collapse
|